Search for: "R&J Manufacturing Company" Results 1 - 20 of 495
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Apr 2024, 10:28 am by admin
Egilman published frequently in the journal, which became a vanity press for his anti-manufacturer, pro-lawsuit industry views. [read post]
13 Apr 2024, 3:33 pm by admin
The FDA’s actions led the drug companies voluntarily to withdraw PPA-containing products. [read post]
4 Mar 2024, 11:50 am by Kenan Farrell
Dexter Axle Company, LLC Court Case Number: 3:24-cv-00190-DRL-MGGFile Date: March 1, 2024Plaintiff: Valcrum, LLCPlaintiff Counsel: Andrew J. [read post]
23 Feb 2024, 10:28 am by Yosi Yahoudai
Welcome to the latest entry on the J&Y Law Firm blog, where we discuss the evolving landscape of automotive law and its impact on Californians. [read post]
16 Feb 2024, 9:05 pm by Carson Turner
In an article for the CATO Institute, David J. [read post]
12 Feb 2024, 6:00 am by Daniel J. Gilman
If the American people foot the bill for a product’s development, why leave it to a private party to decide whether to manufacture and distribute the product at all? [read post]
25 Jan 2024, 5:31 am by Ashley Morgan
Health Care Provider Risks When Ordering and Billing Chelation Therapy Services (January 25, 2024): Although chelation therapy[1] has played an important role in mainstream medicine for many years,[2] it is still considered by many clinicians and regulators to fall within the category of "Complementary and Alternative Medicine. [read post]
31 Oct 2023, 6:26 am
  Across the Federal Government, my Administration will support programs to provide Americans the skills they need for the age of AI and attract the world’s AI talent to our shores — not just to study, but to stay — so that the companies and technologies of the future are made in America. [read post]
24 Oct 2023, 9:01 pm by renholding
So when a new action, examination priority,[5] or Commission rule is relevant to your company, you should digest it and examine which segments of your company have exposure to the same or similar issues. [read post]